glp-1 alternatives for weight loss Comparing Ozempic, Wegovy and Other Drugs Tired of GLP-1s? Comparing Gastric
Description
Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates
Regular follow-up is important
SGLT2 includes Jardiance, Farxiga, and Invokana Source: IQVIA Market Share Library
However, in the last couple of weeks, the generics makers are looking at a price range of 3,000-4,000 to undercut the innovator, said Kovil
